Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Open-label Trial Assessing the Impact on Skin Quality, Hydration, and Barrier of Three (3) Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VI

NCT05932732 is registered in ClinicalTrials.gov with Austin Institute for Clinical Research as lead sponsor.

NCT NCT05932732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05932732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Open-label Trial Assessing the Impact on Skin Quality, Hydration, and Barrier of Three (3) Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VI
Lead sponsor
Austin Institute for Clinical Research
Phase
Phase 4
Overall status
Completed
Start date
November 20, 2023
Completion date
October 9, 2024
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cutis laxa facialis, xeroderma